Synthesis and antimalarial activity of new heterocyclic hybrids based on chloroquine and thiazolidinone scaffolds

FAR Ruiz, RN García-Sánchez, SV Estupiñan… - Bioorganic & medicinal …, 2011 - Elsevier
A series of new 21 chloroquine heterocyclic hybrids containing either benzylamino fragment
or N-(aminoalkyl) thiazolidin-4-one moiety were synthesized and screened for their …

Recent advances on patents of Plasmodium falciparum dihydroorotate dehydrogenase (PfDHODH) inhibitors as antimalarial agents

P Gehlot, VK Vyas - Expert Opinion on Therapeutic Patents, 2023 - Taylor & Francis
Introduction Pyrimidine nucleotides are essential for the parasite's growth and replication.
Parasites have only a de novo pathway for the biosynthesis of pyrimidine nucleotides …

Discovery of Marinoquinolines as Potent and Fast-Acting Plasmodium falciparum Inhibitors with in Vivo Activity

ACC Aguiar, M Panciera… - Journal of medicinal …, 2018 - ACS Publications
We report the discovery of marinoquinoline (3 H-pyrrolo [2, 3-c] quinoline) derivatives as
new chemotypes with antiplasmodial activity. We evaluated their inhibitory activities against …

Antiplasmodial activity of new 4-aminoquinoline derivatives against chloroquine resistant strain

M Sinha, VR Dola, P Agarwal, K Srivastava… - Bioorganic & Medicinal …, 2014 - Elsevier
Emergence and spread of multidrug resistant strains of Plasmodium falciparum has severely
limited the antimalarial chemotherapeutic options. In order to overcome the obstacle, a set of …

Synthesis, characterization and antimalarial activity of quinoline–pyrimidine hybrids

SI Pretorius, WJ Breytenbach, C De Kock… - Bioorganic & medicinal …, 2013 - Elsevier
The aim of this study was to synthesize a series of quinoline–pyrimidine hybrids and to
evaluate their in vitro antimalarial activity as well as cytotoxicity. The hybrids were brought …

Quinoline–pyrimidine hybrids: synthesis, antiplasmodial activity, SAR, and mode of action studies

K Singh, H Kaur, P Smith, C de Kock… - Journal of medicinal …, 2014 - ACS Publications
For the treatment of malaria which affects nearly 200 million people each year and the
continued exacerbation by the emergence of drug resistance to most of the available …

Synthesis of novel α-pyranochalcones and pyrazoline derivatives as Plasmodium falciparum growth inhibitors

G Wanare, R Aher, N Kawathekar, R Ranjan… - Bioorganic & medicinal …, 2010 - Elsevier
Both the lack of a credible malaria vaccine and the emergence and spread of parasites
resistant to most of the clinically used antimalarial drugs and drug combination have …

Novel 4-Aminoquinoline Analogs Highly Active against the Blood and Sexual Stages of Plasmodium In Vivo and In Vitro

FE Sáenz, T Mutka, K Udenze… - Antimicrobial agents …, 2012 - Am Soc Microbiol
New drugs to treat malaria must act rapidly and be highly potent against asexual blood
stages, well tolerated, and affordable to residents of regions of endemicity. This was the …

Identification of novel quinazoline derivatives as potent antiplasmodial agents

A Bouchut, D Rotili, C Pierrot, S Valente… - European Journal of …, 2019 - Elsevier
Despite the recent reductions in the global burden of malaria, this disease remains a
devastating cause of death in tropical and subtropical regions. As there is no broadly …

Design, synthesis, and structure–activity relationship studies of 4-quinolinyl-and 9-acrydinylhydrazones as potent antimalarial agents

C Fattorusso, G Campiani, G Kukreja… - Journal of medicinal …, 2008 - ACS Publications
Malaria is a major health problem in poverty-stricken regions where new antiparasitic drugs
are urgently required at an affordable price. We report herein the design, synthesis, and …